10.1074/jbc.M209195200 297 StitzelM
Thus, at least two plasmalogen-selective enzymes of the phospholipase A 2 type degrade plasmalogens to release arachidonic and docosahexaenoic acids from position sn -2 for eicosanoid or docosanoid production, respectively, as part of signalling mechanisms
Nevertheless, we cannot totally exclude the possibility of unknown disturbing factors in these hospitalized patients
LY294002 and SP600125 were from EMD (Gibbstown, NJ, USA) Western blot analysis The antibodies used for western blotting included those against stress-activated protein kinase (SAPK)/JNK, phospho-SAPK/JNK (Thr183/Tyr185), caspase-7, caspase-9, phospho-Bcl-2 (Ser70), and poly(ADP-ribose) polymerase (PARP) (Cell Signaling Technology, Danvers, MA, USA), cytochrome c and -actin (Sigma, St Louis, MO, USA), cytochrome oxidase subunit IV (Cox IV
Other conditions of registration include pharmacovigilance, risk management, safety reports or alerts, management of complaints or failures, quality audits and traceability of the medicine batch or medical device unit